PDB21 A COST COMPARISON OF A BASAL BOLUS REGIMEN (INSULIN GLARGINE AND INSULIN GLULISINE) WITH A CONVENTIONAL PRE-MIXED INSULIN REGIMEN IN TYPE-2 DIABETES PATIENTS – THE GINGER STUDY
May 1, 2011, 00:00
10.1016/j.jval.2011.02.529
https://www.valueinhealthjournal.com/article/S1098-3015(11)00668-1/fulltext
Title :
PDB21 A COST COMPARISON OF A BASAL BOLUS REGIMEN (INSULIN GLARGINE AND INSULIN GLULISINE) WITH A CONVENTIONAL PRE-MIXED INSULIN REGIMEN IN TYPE-2 DIABETES PATIENTS – THE GINGER STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00668-1&doi=10.1016/j.jval.2011.02.529
First page :
A94
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1092